MARSHALL WACE, LLP - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 152 filers reported holding IMMUNITYBIO INC in Q1 2022. The put-call ratio across all filers is 2.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q1 2023$426,683
+41.9%
234,441
+295.3%
0.00%0.0%
Q4 2022$300,691
+17.5%
59,308
+15.0%
0.00%0.0%
Q3 2022$256,000
-70.3%
51,590
-66.3%
0.00%
-50.0%
Q1 2022$861,000
-41.9%
153,282
-37.1%
0.00%
-33.3%
Q4 2021$1,481,000243,5190.00%
Other shareholders
IMMUNITYBIO INC shareholders Q1 2022
NameSharesValueWeighting ↓
CVI Holdings, LLC 226,916$383,4880.76%
HARBOURVEST PARTNERS LLC 335,709$567,3480.19%
ALLEN HOLDING INC /NY 687,571$1,161,9950.16%
ARMISTICE CAPITAL, LLC 3,476,000$5,874,4400.09%
Clearwater Capital Advisors, LLC 394,599$666,8730.08%
SHEETS SMITH WEALTH MANAGEMENT 273,879$462,8560.07%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$162,9720.06%
WEALTH EFFECTS LLC 53,500$90,4150.04%
Virtus ETF Advisers LLC 34,461$58,2390.04%
FISHMAN JAY A LTD/MI 162,000$273,7800.04%
View complete list of IMMUNITYBIO INC shareholders